Role for early-differentiated natural killer cells in infectious mononucleosis

Tarik Azzi, Anna Lünemann, Anita Murer, Seigo Ueda, Vivien Béziat, Karl Johan Malmberg, Georg Staubli, Claudine Gysin, Christoph Berger, Christian Münz, Obinna Chijioke, David Nadal

Research output: Contribution to journalArticlepeer-review

157 Scopus citations

Abstract

A growing body of evidence suggests that the humannatural killer (NK)-cell compartment is phenotypically and functionally heterogeneous and is composed of several differentiation stages. Moreover, NK-cell subsets have been shown to exhibit adaptive immune features during herpes virus infection in experimental mice and to expand preferentially during viral infections in humans. However, both phenotype and role of NK cells during acute symptomatic Epstein-Barr virus (EBV) infection, termed infectious mononucleosis (IM), remain unclear. Here, we longitudinally assessed the kinetics, the differentiation, and the proliferation of subsets of NK cells in pediatric IM patients. Our results indicate that acute IM is characterized by the preferential proliferation of early-differentiated CD56dim NKG2A+ immunoglobulin-like receptor- NK cells.Moreover, this NK-cell subset exhibits features of terminal differentiation and persists at higher frequency during at least the first 6 months after acute IM. Finally, we demonstrate that this NK-cell subset preferentially degranulates and proliferates on exposure to EBV-infected B cells expressing lytic antigens. Thus, early-differentiated NK cellsmight play a key role in the immune control of primary infection with this persistent tumor-associated virus.

Original languageEnglish
Pages (from-to)2533-2543
Number of pages11
JournalBlood
Volume124
Issue number16
DOIs
StatePublished - 16 Oct 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'Role for early-differentiated natural killer cells in infectious mononucleosis'. Together they form a unique fingerprint.

Cite this